A patient with nephrotic syndrome and severe edema is on furosemide 80 mg twice daily without adequate diuretic response ('diuretic resistance'). The nephrologist adds metolazone. What is the pharmacological rationale for this combination specifically in nephrotic syndrome?

• A Metolazone inhibits carbonic anhydrase in the proximal tubule, increasing bicarbonate delivery to the loop of Henle, potentiating furosemide's effect on the Na-K-2Cl cotransporter
• B In nephrotic syndrome, furosemide binds urinary albumin; metolazone displaces furosemide from albumin in the tubular lumen, freeing active furosemide
• C Metolazone inhibits distal tubule NaCl cotransporter (NCC), blocking sodium reabsorption at the site where compensatory reabsorption occurs when loop diuretics are used; combination achieves 'sequential nephron blockade' causing profound natriuresis beyond what either agent achieves alone ✓
• D Metolazone has a higher oral bioavailability than furosemide in edematous states due to less gut edema, achieving higher plasma levels

Explanation

Diuretic resistance in nephrotic syndrome has multiple mechanisms including: hypoalbuminemia reducing furosemide binding to albumin (it is protein-bound for tubular secretion), compensatory increased sodium reabsorption at the distal nephron in response to loop diuretic, and increased renin-angiotensin-aldosterone activation. Metolazone inhibits the thiazide-sensitive Na-Cl cotransporter (NCC) in the distal convoluted tubule. This 'sequential nephron blockade' — blocking sodium reabsorption at both the thick ascending limb (furosemide/loop diuretic) AND the distal tubule (metolazone/thiazide) — produces a synergistic, often massive natriuresis exceeding that of either drug alone. Metolazone is specifically preferred over other thiazides for this combination because it maintains efficacy even when GFR is very low (acts at GFR <30 mL/min), unlike many thiazides. However, risk of profound hypokalemia requires careful electrolyte monitoring.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.